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This Month in the Journal
This month, the focus in both of our ongoing series,
“Insights from Model Systems” and “Human Genetics
’97,” is on dynamic aspects of chromatin. Feil and Kelsey
(p. 1213) discuss chromatin as a carrier of epigenetic
information in genomic imprinting. They describe the
use of experimental techniques developed by mouse em-
bryologists to address the mechanisms of imprinting in
mouse and human cells. Robertson and Jones (p. 1220)
discuss the multiple roles of DNA methylation in tu-
morigenesis. DNA methyltransferase, they argue, not
only alters the expression of tumor-suppressor genes at
several levels but may also affect the activity and the
cell-cycle regulation of DNA repair in precancerous cells.
Finally, Choo (p. 1225) discusses latent centromeres,
DNA structures that lack the repeat sequences found in
normal centromeres but that can be activated to form
neocentromeres. Once activated, these structures serve
as nucleation sites for spindle formation, allowing chro-
mosome fragments to segregate normally during cell
division.
Human CAC, Cloning and Mutation Detection, by
Huizing et al. (p. 1239)
Mutations in any of the genes involved in mitochondrial
b-oxidation of fatty acids cause defects in ketone-body
formation during fasting, and they may lead to coma
and death in infancy. Huizing et al. have provided the
first molecular description of a defect in CAC, which
encodes the transporter protein that provides substrate
fatty acids to the oxidative enzymes in the mitochondrial
matrix. Huizing et al., who cloned the rat CAC cDNA,
now report the sequence of its human homologue. They
also identify a homozygous point mutation in CAC in
a girl who, unlike other known CAC-deficient individ-
uals, survived the neonatal symptoms of impaired b-
oxidation. It is possible that her survival and subsequent
good health are the result of her carrying a relatively
mild CAC allele with some residual, but undetected, car-
rier activity.
Novel Alleles of CCR5, by Carrington et al. (p. 1261)
The common D32 mutation in the chemokine-receptor
gene CCR5 is found disproportionately among long-
term survivors of HIV infection. The CCR5 protein is
expressed on macrophages, where it serves as a core-
ceptor for HIV in the early, macrophage-tropic (M-tro-
pic) stage of infection. Cells homozygous for D32 are
resistant to M-tropic isolates of the virus, and even het-
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erozygosity is associated with delayed onset of AIDS. In
a set of ∼1,400 individuals at risk for AIDS, Carrington
and colleagues have now identified 16 novel polymor-
phisms in the CCR5 gene, of which 1 is a probable null
allele and 13 are expected to lead to subtle changes in
protein sequence. None of these polymorphisms were
found in the homozygous state, but four were found
along with the D32 allele in compound heterozygotes.
The authors suggest that one or more of these rare se-
quence variants may be associated with delayed or re-
stricted HIV progression.
Splicing Defects in the COL3A1 Gene, by Schwarze
et al. (p. 1276)
In Ehlers-Danlos syndrome type IV, dominant mutations
in the COL3A1 gene disrupt the synthesis and deposi-
tion of type III procollagen, and several tissues are prone
to rupture in affected individuals. Approximately a third
of the known mutations in this gene affect splicing.
Schwarze and colleagues have identified point mutations
in 33 splicing-defective alleles of COL3A1. These mu-
tations are widely scattered throughout the gene, but
virtually all of them affect splice-donor sites and lead to
single-exon skipping. As with other collagen genes, ex-
ons in COL3A1 encode units of multiple Gly-X-Y re-
peats and remain in the same reading frame. Exon
skipping, therefore, does not introduce premature-ter-
mination codons, so the altered mRNAs are not suscep-
tible to nonsense-mediated decay. Schwarze et al. find
that misspliced mRNAs and the proteins that they en-
code do, in fact, accumulate in fibroblasts and cause
abnormal synthesis of type III collagen. The authors sug-
gest that most splice acceptor–site mutations would have
different molecular consequences. Clinical or biochem-
ical ascertainment criteria, they speculate, exclude those
mutations that create null alleles of COL3A1.
NF2 Gene in Schwannomatosis, by Jacoby et al. (p.
1293)
Jacoby et al. argue here, on both clinical and genetic
grounds, that neurofibromatosis 2 (NF2) and schwan-
nomatosis, two conditions that involve Schwann-cell
neoplasias and the tumor-suppressor gene NF2, should
be considered distinct disorders. Unlike NF2, schwan-
nomatosis typically spares the vestibular nerves, and,
whereas germ-line transmission of a mutation in NF2 is
the rule in NF2, schwannomatosis is usually sporadic.
Somatic loss of heterozygosity (LOH) provides the “sec-
ond hit” in NF2, as expected when a tumor-suppressor
gene is involved. In schwannomatosis, even when LOH
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in NF2 is observed in tumors, the other mutation in the
gene may vary among the tumors found in a single in-
dividual. Jacoby et al. find that, within an affected fam-
ily, point mutations occur preferentially on one inherited
allele, with somatic loss of the other allele. They suggest
that a novel disease mechanism operates in schwannom-
atosis, whereby one allele of NF2 is specifically subject
to—or is unable to repair—spontaneous somatic
mutations.
Point Mutation in Hair Roots, by Bendall et al. (p.
1303)
Bendall and coworkers have examined the distribution
of a novel mtDNA polymorphism in different tissues
from a heteroplasmic family. In three heteroplasmic in-
dividuals in this group, the proportion of polymorphic
mtDNAs varies widely among hair roots, whereas blood
and buccal cells show consistent levels of heteroplasmy.
The authors suggest that the variability seen in hair roots
reflects their independent development from a small
number of progenitor cells in early fetal life; the heter-
oplasmy seen in blood and buccal cells, on the other
hand, reflects an average of a large number of stem cells.
This unexpected level of somatic variegation suggests
that mtDNA partitioning should be viewed as a dynamic
process occurring at least through early fetal
development.
PAH Genotypes: HPA Phenotypes, by Kayaalp et al.
(p. 1309)
Because genetic and clinical screening of newborns for
phenylketonuria (PKU) has become standard practice in
much of the world, the phenylalanine hydroxylase gene,
PAH, is among the most widely studied of human disease
genes, and PKU represents a textbook example of a sim-
ple Mendelian recessive disorder. However, Kayaalp et
al., who have assembled data on the disease phenotypes
associated with PAH genotypes, now dispute this view.
Most phenotypes can be predicted from the enzymatic
activity seen when the corresponding alleles are ex-
pressed in cultured cells, but, as the authors emphasize,
some genotypes are associated with surprisingly mild or
severely variable disease phenotypes. Thus, Kayaalp et
al. argue that the PKU phenotype is subject to modifi-
cation by other factors—and, possibly, by other genes.
Their data also raise concerns about enzyme-activity
studies that are performed in transfected cells.
Segregation Analysis of Recurrent Depression, by
Marazita et al. (p. 1370)
The study by Marazita and colleagues on unipolar de-
pression is one of several in this issue that highlight the
promise and the frustrations of studying the genetics of
complex psychiatric disorders. These investigators fo-
cused on 50 probands with early-onset recurrent uni-
polar depression (UPD) and on their families, because
these probands are expected to show relatively clear in-
heritance of affective disease. Because hereditary factors
might predispose either to UPD specifically or to affec-
tive diseases in general, Marazita et al. analyzed their
data separately with either a narrow or a broad con-
ception of affected status. In each case, the data are fully
consistent with a genetic influence on affective disease,
but a model incorporating ordinary Mendelian assump-
tions about transmissibility is favored only with the
broad definition of affected status.
Linkage of Positive Symptoms of Schizophrenia, by
Brzustowicz et al. (p. 1388)
Linkage of schizophrenia to a susceptibility locus on 6p
has been found in some studies but has been disputed
in others. Brzustowicz et al. have reexamined this issue,
and they suggest here that the diagnostic categories ap-
plied to this disorder may be at fault for some of this
confusion. Applying two different categorical definitions
of schizophrenia, they failed to find linkage to 6p in a
set of 10 large families. However, observing that the
symptoms of schizophrenia may segregate in families
even when categorical diagnoses do not, the authors fol-
lowed positive and negative measures of schizophrenia
separately as quantitative traits. They found that positive
features, those associated with psychotic behaviors, were
significantly linked to markers on 6p. A quantitative-
trait locus mapping to this region may affect the severity
of psychosis, whereas other features of the disease may
be subject to other influences.
Linkage of Bipolar Disorder to Chromosome 18, by
McMahon et al. (p. 1397)
Bipolar affective disorder (BPAD) comprises several con-
ditions, including bipolar disorders I and II. McMahon
and coworkers, along with several other groups, have
previously reported linkage of BPAD to a broad region
of 18q. Now, working with a set of 30 newly ascertained
pedigrees, McMahon et al. find strong evidence of link-
age to a 14-cM region that overlaps slightly with the
previously identified region. However, a parent-of-origin
effect that was seen before is not as obvious in the pres-
ent data, and it remains uncertain whether the 14-cM
region is identical to the locus mapped before or to a
proposed bipolar I locus reported by another group.
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